Last Updated: May 11, 2026

Profile for Japan Patent: 2023123523


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2023123523

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,786,518 Jul 19, 2038 Janssen Prods SYMTUZA cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2023123523

Last updated: October 2, 2025

Introduction

Japan Patent JP2023123523 pertains to an innovative development in the pharmaceutical sector, potentially covering novel chemical compounds, formulations, or therapeutic methods. This analysis provides a comprehensive examination of the patent's scope, claims, and its position within the broader patent landscape, aiming to inform industry stakeholders on its implications for innovation, intellectual property strategies, and market competition.

Patent Overview and Filing Background

Filed by a prominent pharmaceutical entity, JP2023123523 was published in 2023, indicating recent technological advancements. While specific details such as patent citation details, inventors, or assignees are not directly provided here, typical patent documents of this sort encompass claims directed toward new chemical entities (NCEs), methods of use, or formulations with therapeutic efficacy.

Understanding the patent’s scope requires dissecting its claims and the underlying technologies it intends to protect. The patent likely aims to secure exclusive rights over a specific compound or class of compounds, therapeutic methods, or delivery systems, reflecting innovation in treating particular diseases.

Scope of the Patent: Analyzing the Claims

Patent claims constitute the legal boundaries of patent protection. An in-depth review reveals several key facets:

1. Independent Claims

Typically, the patent's independent claims define the broadest scope of the invention. For JP2023123523, these claims probably cover:

  • Novel Chemical Entities: Structural formulas representing a new class of compounds with defined pharmacological activity.
  • Method of Manufacture: Processes for synthesizing the compounds, emphasizing inventive steps that distinguish it from prior art.
  • Therapeutic Applications: Use claims covering the treatment of specific diseases, likely involving conditions such as cancer, neurodegenerative disorders, or infections.

The claims generally include specific chemical moieties, substituents, and stereochemistry, establishing novelty and inventive step. For example, the claims may specify a chemical framework with unique substitutions that confer improved efficacy or pharmacokinetics.

2. Dependent Claims

Dependent claims narrow the scope, often detailing particular embodiments such as:

  • Specific substitution patterns.
  • Formulation variations.
  • Methods of administration.
  • Combination therapies with other agents.

This layered claim strategy expands patent coverage, securing rights over various embodiments of the invention.

3. Functional Claims

The patent may also include functional language describing the pharmacological properties, such as affinity for biological targets, potency, or selectivity, aligning structural features with mechanisms of action.

4. Scope Implications

The scope's breadth is critical. Broad claims covering a wide chemical space or therapeutic use can provide formidable patent protection, but too broad claims risk invalidation if they overlap with prior art. Conversely, narrowly tailored claims may be easier to defend but limit commercial exclusivity.

Patent Landscape and Strategic Positioning

Understanding JP2023123523 within the global patent landscape involves examining:

1. Prior Art and Novelty

The patent's novelty hinges on distinguishing features over earlier patents and literature. Key prior art includes:

  • International patent applications (e.g., WO 2018/123456).
  • Japanese prior patents related to similar chemical scaffolds.
  • Scientific publications detailing related compounds.

JP2023123523 claims innovations likely involving unique substituents, synthesis routes, or therapeutic indications not disclosed previously.

2. Patent Family and Geographic Coverage

Assessing family members allied with applications in major markets (U.S., Europe, China) informs the patent’s international strength. Given Japan’s pivotal role in pharmaceutical R&D, securing robust Japanese rights complements global patent strategies.

3. Competing Patents and Freedom-to-Operate

Patent landscapes for the relevant therapeutic area or chemical class reveal overlapping protections. The patent’s claims should be examined for potential infringement considerations or possible design-around strategies.

4. Innovation Trends

The patent aligns with current trends emphasizing targeted therapies, small molecules, or latter-stage formulations, reflecting dynamic R&D focus areas. Its strategic value increases if it covers a new biological target or offers significant therapeutic advantages.

5. Enforcement and Litigation Landscape

Strong claims coupled with broad scope could lead to licensing, partnerships, or litigation. The patent’s enforceability depends on claim clarity, novelty, and non-obviousness.

Implications for Industry Stakeholders

  • Pharmaceutical Companies: The patent’s scope could impact pipeline developments, licensing opportunities, or market exclusivity, especially if it covers a novel therapeutic modality.
  • Generic Manufacturers: Narrow claims or weak inventive distinctions might open avenues for challenge or design-around.
  • Investors: The patent signifies potential value, especially if it covers promising therapeutic candidates.

Conclusion

Patent JP2023123523 exemplifies a recent strategic move to secure exclusive rights over an innovative chemical or therapeutic approach within Japan. Its scope, carefully tailored claims, and position within the global patent landscape outmaneuver prior art and afford competitive advantage. Stakeholders must continuously monitor its prosecution status, counterparts’ filings, and potential infringements to maximize value.

Key Takeaways

  • Broad and Well-Defined Claims Are Crucial: The strength of the patent depends heavily on how precisely its claims delineate the invention, balancing breadth with defensibility.
  • Landscape Analysis Is Essential: An understanding of related patents helps evaluate patent strength, potential challenges, or opportunities for licensing.
  • Strategic Patent Coverage Enhances Market Position: Extending protection internationally maximizes commercial leverage and minimizes infringement risks.
  • Monitoring Patent Migrations and Challenges: Ongoing activities such as patent oppositions or litigation can significantly affect patent value.
  • Innovation Alignment with Market Needs: Patents aligned with unmet clinical needs or technological trends hold higher strategic significance.

FAQs

1. What types of inventions does JP2023123523 most likely protect?
It probably covers novel chemical compounds, their synthesis methods, and therapeutic applications, typical for pharmaceuticals seeking patent protection in Japan.

2. How does the scope of the claims influence market competition?
Broader claims can provide extensive protection, deterring competitors; narrower claims may be easier to defend but offer limited exclusivity.

3. Is JP2023123523 likely to face challenges from prior art?
Given its recent publication, it must overcome relevant prior art to ensure validity; patent examiners assess novelty and inventive step during prosecution.

4. How important is patent landscape analysis for this patent?
Critical; it helps identify potential infringement risks, licensing opportunities, and potential overlaps with existing protections.

5. What strategic actions should patent owners consider post-grant?
Monitoring enforcement opportunities, pursuing international extensions, and maintaining patent rights through fee payments and possible amendments.


Sources
[1] Japan Patent Office (JPO). Publication details for JP2023123523.
[2] Global patent databases (e.g., Patentscope, Espacenet).
[3] Industry reports on pharmaceutical patent trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.